# The Angioshield Study Feasibility II

> **NCT02543047** · NA · COMPLETED · sponsor: **Neograft Technologies, Incorporated** · enrollment: 34 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Angioshield

## Key facts

- **NCT ID:** NCT02543047
- **Lead sponsor:** Neograft Technologies, Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-03
- **Final completion:** 2018-03-07
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02543047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02543047, "The Angioshield Study Feasibility II". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02543047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*